LPM6690176
/ Luye Group
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 15, 2024
First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
(clinicaltrials.gov)
- P1 | N=102 | Recruiting | Sponsor: Luye Pharma Group Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
February 05, 2024
First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
(clinicaltrials.gov)
- P1 | N=102 | Not yet recruiting | Sponsor: Luye Pharma Group Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1